• Join
  • Login
  • Contact

Search abstracts / presentations

Drug use evaluation of liraglutide in type 2 diabetes mellitus patients

  • In: Posters: Hospital Pharmacy Section
  • At: Bangkok (Thailand) (2014)
  • Type: Poster
  • Poster code: POS-HPS021
  • By: HUANG, Yun-Ting (Taipei, China Taiwan)
  • Co-author(s): Tsai, Tzu-Cheng (, Taipei, China Taiwan)
    Chen, Wei-Li (, Taipei, China Taiwan)
    Deng, Shin-Tarng (, Taipei, China Taiwan)
  • Abstract:

    1. Background
    Diabetes mellitus (DM) and its complications have been major cause of death in theworld. A new glucagon-like peptide 1 (GLP-1) analog, liraglutide, was availablein medical hospital in April 2013. Liraglutide and exenatide are both GLP-1analogs, however, patients often withdraw exenatide due to adverse effects.
    2. Aims
    To investigate..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses